Product Information

MARAVIROC 150 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $8.3209 per EA under NDC 70710193006. Its NADAC has been published 61 times since Sep 24, 2025.

FDA first approved this application on May 13, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MARAVIROC 150 MG TABLET

Maraviroc
$8.3209per EA

Strength

150 mg/1

NDC

70710193006

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

MARAVIROC

Approval Type

Generic (ANDA)

FDA Application

ANDA217880

FDA Approved

5/13/2025

TE Code

AB

On Market Since

5/23/2025

Pharmacological Classes

CCR5 Co-receptor Antagonist
Chemokine Co-receptor 5 Antagonists

Price Statistics

The NADAC for MARAVIROC 150 MG TABLET has been published 61 times since Sep 24, 2025, and over the history we have for it it has declined 9.1%. The table below summarizes its recorded NADAC range and movement.

Current price$8.3209 per EA
All-time high$9.1496 (Oct 14, 2026)
All-time low$8.2857 (Oct 21, 2026)
52-week high$9.1496
52-week low$8.2857
Median price$9.1496
Average price$9.0794
Largest weekly change-9.4% (Oct 21, 2026)
Weeks tracked61
Tracking sinceSep 24, 2025

Price History

1W

+0.4%

1M

-9.1%

3M

-9.1%

6M

-9.1%

1Y

-9.1%

3Y

N/A

5Y

N/A

All

-9.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MARAVIROC 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MARAVIROC 150 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $8.3209 per EA (NDC 70710193006), effective Nov 18, 2026.

How has the price of MARAVIROC 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for MARAVIROC 150 MG TABLET has declined 9.1%. It has been tracked across 61 weekly CMS publications since Sep 24, 2025.

What are the highest and lowest recorded NADAC prices for MARAVIROC 150 MG TABLET?

Since Sep 24, 2025, the NADAC for MARAVIROC 150 MG TABLET has ranged from a low of $8.2857 (Oct 21, 2026) to a high of $9.1496 (Oct 14, 2026), with a median of $9.1496 per EA.

Are there cheaper alternatives to MARAVIROC 150 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MARAVIROC 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MARAVIROC 150 MG TABLET?

MARAVIROC 150 MG TABLET (NDC 70710193006) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.